DSGN
NASDAQ
US
Design Therapeutics, Inc. - Common Stock
$11.23
▲ +$0.22
(+2.00%)
Vol 314K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$534.3M
ROE
-30.6%
D/E
0.00
Beta
1.64
52W
$3–$10
Wall Street Consensus
12 analysts · Apr 20265
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.36 | $-0.27 | +$0.09 |
| Sep 2025 | $-0.35 | $-0.30 | +$0.05 |
| Jun 2025 | $-0.34 | $-0.34 | $0.00 |
| Mar 2025 | $-0.29 | $-0.31 | $-0.02 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$13.0M | -$13.7M | -$17.7M | -$19.1M | -$17.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -27.1% | -27.2% | -27.2% | -27.2% | -30.6% | -30.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 25.13 | 25.13 | 25.13 | 25.13 | 18.71 | 18.71 |
Key Ratios
ROA (TTM)
-29.2%
P/B
1.4
EPS (TTM)
$-1.19
CF/Share
$-1.28
52W High
$10.31
52W Low
$2.60
$2.60
52-Week Range
$10.31
Financial Health
Free Cash Flow
-$11.2M
Net Debt
-$13.3M
Cash
$15.1M
Total Debt
$1.7M
As of Sep 30, 2025
How does DSGN compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
DSGN valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.4
▼
41%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
DSGN profitability vs Biotechnology peers
ROE
-30.6%
▲
55%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-29.2%
▲
38%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
DSGN financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
18.7
▲
321%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.6
▲
69%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
DSGN fundamentals radar
DSGN
Peer median
Industry
DSGN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
DSGN vs peers: key metrics
Top Holders
Top 5: 30.39%SR One Capital Management, …
10.58%
$68.7M
Point72 Asset Management, L…
8.71%
$56.6M
Logos Global Management LP
4.05%
$26.3M
Baker Bros. Advisors, LP
3.62%
$23.5M
Blackrock Inc.
3.43%
$22.3M
As of Dec 31, 2025
Latest News
No related news yet